ADB-P7AICA

ADB-P7AICA

Chemical structure of ADB-P7AICA

ADB-P7AICA is a synthetic cannabinoid that has been identified in various designer drug products. It is part of a class of compounds that are often used as substitutes for cannabis due to their psychoactive effects. These compounds are typically sprayed onto plant material and smoked, or they are sold as liquids to be vaporized in e-cigarettes.

Chemical Structure

ADB-P7AICA is chemically related to other synthetic cannabinoids, which are designed to mimic the effects of tetrahydrocannabinol (THC), the active component of cannabis. The structure of ADB-P7AICA includes a core indazole structure, which is common among many synthetic cannabinoids. The specific chemical structure of ADB-P7AICA is shown in the image to the right.

Pharmacology

Synthetic cannabinoids like ADB-P7AICA act on the cannabinoid receptors in the brain, primarily the CB1 receptor, which is responsible for the psychoactive effects of THC. These compounds can have a much higher potency than THC, leading to more intense effects and a higher risk of adverse reactions.

Legal Status

The legal status of ADB-P7AICA varies by country. Many jurisdictions have moved to ban synthetic cannabinoids due to their potential for abuse and the health risks they pose. In some regions, ADB-P7AICA may be classified as a controlled substance, making its sale, possession, and use illegal.

Health Risks

The use of synthetic cannabinoids like ADB-P7AICA has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, hallucinations, and seizures. In some cases, use of these substances has been linked to severe outcomes, including acute kidney injury and death.

Related Pages

• Synthetic cannabinoids
• Cannabinoid receptor
• Tetrahydrocannabinol
• Designer drugs